Cargando…

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?

Right ventricular failure is a leading cause of mortality in patients with pulmonary arterial hypertension (PAH). However, up to 25% of such patients die unexpectedly, without warning signs of hemodynamical decompensation. We previously documented that pulmonary artery (PA) dilatation significantly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Florczyk, Michał, Wieteska, Maria, Kurzyna, Marcin, Gościniak, Piotr, Pepke-Żaba, Joanna, Biederman, Andrzej, Torbicki, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896856/ https://www.ncbi.nlm.nih.gov/pubmed/29251549 http://dx.doi.org/10.1177/2045893217749114

Ejemplares similares

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Kacprzak, Aneta, et al.
Publicado: (2021)

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters
por: Mańczak, Rafał, et al.
Publicado: (2020)

Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors
por: Wieteska-Miłek, Maria, et al.
Publicado: (2022)

Long COVID syndrome after SARS‐CoV‐2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Wieteska‐Miłek, Maria, et al.
Publicado: (2023)

Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension
por: Piłka, Michał, et al.
Publicado: (2020)

Circulating Blood-Based Biomarkers in Pulmonary Hypertension
por: Banaszkiewicz, Marta, et al.
Publicado: (2022)

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kurzyna, Marcin, et al.
Publicado: (2015)

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021)

Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Piłka, Michał, et al.
Publicado: (2021)

An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgery
por: Darocha, Szymon, et al.
Publicado: (2022)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
por: Kurzyna, Marcin, et al.
Publicado: (2017)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2021)

Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2020)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
por: Kopeć, Grzegorz, et al.
Publicado: (2020)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
por: Stącel, Tomasz, et al.
Publicado: (2021)

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension
por: Bunclark, Katherine, et al.
Publicado: (2021)

Effective Balloon Pulmonary Angioplasty in a Patient with Chronic Thromboembolic Complications after Ventriculoatrial Shunt for Hydrocephalus in von Hippel–Lindau Disease
por: Gościniak, Piotr, et al.
Publicado: (2022)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Presentation and management of pulmonary artery sarcoma
por: Wong, Han Hsi, et al.
Publicado: (2015)

Overexpression of PD-1 on Peripheral Blood Lymphocytes in Patients with Idiopathic Pulmonary Arterial Hypertension and Its Association with High Viral Loads of Epstein-Barr Virus and Poor Clinical Parameters
por: Tomaszewski, Michał, et al.
Publicado: (2020)

Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies
por: Grady, Duncan, et al.
Publicado: (2017)

Precision medicine: The future of diagnostic approach to pulmonary hypertension?
por: Kedzierski, Piotr, et al.
Publicado: (2019)

Pulmonary Hypertension: Diagnosis and Management
por: Torbicki, Adam
Publicado: (2021)

Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries
por: Hagan, Guy, et al.
Publicado: (2011)

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Pulmonary Artery Dissection: A Fatal Complication of Pulmonary Hypertension
por: Zhang, Chuanchen, et al.
Publicado: (2016)

Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
por: Howard, Luke S.G.E., et al.
Publicado: (2013)

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
por: Siennicka, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3fedsacu40ct1ju0onbog5ik8j